Citadel Advisors’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.44M Buy
33,800
+5,700
+20% +$230K ﹤0.01% 6809
2025
Q4
$1.05M Buy
28,100
+1,200
+4% +$40.2K ﹤0.01% 7282
2025
Q3
$795K Buy
26,900
+13,700
+104% +$318K ﹤0.01% 8040
2025
Q2
$311K Buy
13,200
+3,700
+39% +$77.2K ﹤0.01% 9730
2025
Q1
$172K Buy
9,500
+600
+7% +$11.8K ﹤0.01% 10668
2024
Q4
$152K Sell
8,900
-400
-4% -$6.92K ﹤0.01% 10872
2024
Q3
$137K Buy
9,300
+7,400
+389% +$92.7K ﹤0.01% 10686
2024
Q2
$21.6K Sell
1,900
-700
-27% -$7.64K ﹤0.01% 12563
2024
Q1
$28.3K Buy
+2,600
New +$26K ﹤0.01% 12749

Other funds holding BTSG

Citadel Advisors's BTSG Position: Q1 2026 in Review

Citadel Advisors increased its BrightSpring Health Services (BTSG) stake by 1,988% in Q1 2026, buying an estimated $118M and bringing the position to 3,087,924 shares worth $132M. The position accounts for 0.02% of the portfolio, ranked #644.

Citadel Advisors first reported a position in BTSG in Q1 2024 and has held it in 9 quarters since. 335 funds tracked by Wall St. Rank hold BTSG as of Q1 2026.

  • Citadel Advisors held 3,087,924 shares of BrightSpring Health Services worth $132M as of Q1 2026.
  • Citadel Advisors bought 2,940,026 BrightSpring Health Services shares in Q1 2026, an estimated $118M.
  • BrightSpring Health Services made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #644 holding.
  • Citadel Advisors first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 9 quarters since.
  • 335 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.